Helianthin induces antiproliferative effect on human glioblastoma cells in vitro.

Journal of Neuro-oncology
Oana AlexandruAnica Dricu

Abstract

A major focus of brain cancer research today is to translate understanding of glioma biology into advances in treatment, by exploring the potential of target therapy. Here we investigated the ability of three compounds belonging to the chemical class of azo dyes (methyl red, methyl yellow, and helianthin) to inhibit glioblastoma (GB) cell growth in vitro. Our results showed that helianthin induced cytotoxicity in two GB cell cultures, cell lines 18 and 38, whereas methyl red and methyl yellow were not cytotoxic. The effect of helianthin on EGFR, IGF-1R, and their common intracellular signaling via PI3-K and ERK1/2 was also analyzed. Treatment with helianthin down-regulated EGFR and IGF-1R activity in both cell lines. Helianthin treatment blocked ERK1/2 phosphorylation without affecting PI3K activity in cell line 18 and reduced both PI3K and ERK1/2 in GB 38 cell line. The cell death was accompanied by degradation of PARP without affecting BCL2 expression in both GB cell cultures. Because of the genetic heterogeneity of malignant gliomas, we tested the effect of helianthin on other two primary GB lines (11 and 15) and two early-passage GB cultures (BT1GB and BT2GB), to assess the general nature of the anti-tumor effect of the dru...Continue Reading

References

Jan 1, 1992·Virchows Archiv. A, Pathological Anatomy and Histopathology·R M AgostiO D Wiestler
Sep 14, 1992·Neuroscience Letters·G MelinoS L Lightman
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P A HumphreyD D Bigner
Feb 1, 1991·The Journal of Clinical Investigation·O M El-BadryM A Israel
Sep 1, 1990·Biochemical Pharmacology·A Levitzki
Jul 1, 1990·The Journal of Clinical Endocrinology and Metabolism·M J Merrill, N A Edwards
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A J WongB Vogelstein
Jun 1, 1983·The Journal of General Virology·H V Thorne, G F Clarke
Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Jul 1, 1994·Journal of Pharmaceutical Sciences·J Gautam, H Schott
Jan 24, 1998·Journal of Neuro-oncology·R P GlickT G Unterman
Jan 8, 1999·Brain Tumor Pathology·N SugawaT Okabe
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jan 1, 1997·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·W Zumkeller
Nov 1, 2000·Cell·J Schlessinger
Dec 15, 2000·Oncogene·F A Al-Obeidi, K S Lam
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D W AndrewsR D Aiken
Sep 12, 2001·Neuro-oncology·P Kleihues, H Ohgaki
Feb 14, 2002·Trends in Molecular Medicine·Esther ZwickAxel Ullrich
Jun 1, 2002·Science·Lewis C Cantley
Jul 18, 2002·Nature Reviews. Drug Discovery·Margaret A Somerville
May 28, 2003·Cancer Letters·Derek LeRoith, Charles T Roberts
Nov 26, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeremy N RichHenry S Friedman
Jun 3, 2004·Nature Reviews. Molecular Cell Biology·Stevan R Hubbard
Dec 23, 2004·Endocrine-related Cancer·Christian F SingerErnst Kubista
Jan 11, 2005·The Journal of Pathology·E FoulstoneA B Hassan
Jan 31, 2006·Neuro-oncology·Sara HoffmanBridget J McCarthy
Jun 9, 2006·Expert Review of Anticancer Therapy·Patrick Y WenJan Drappatz

❮ Previous
Next ❯

Citations

Oct 7, 2020·Journal of Immunoassay & Immunochemistry·Cristina HorescuPurcaru Stefana Oana
Jan 14, 2021·International Journal of Molecular Sciences·Alexandru OpritaAni-Simona Sevastre
Jun 3, 2021·International Journal of Molecular Sciences·Ani-Simona SevastreAnica Dricu
Oct 23, 2021·Experimental and Therapeutic Medicine·Ani-Simona SevastreAnica Dricu

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.